Casdin Capital, LLC Blueprint Medicines Corp Transaction History

Casdin Capital, LLC

$1.16 Billion
Q2 2024

A detailed history of Casdin Capital, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Casdin Capital, LLC holds 326,378 shares of BPMC stock, worth $28.1 Million. This represents 3.03% of its overall portfolio holdings.

Number of Shares

326,378

Previous 326,378 -0.0%

Holding current value

$28.1 Million

Previous $35.2 Million -0.0%

% of portfolio

3.03%

Previous 3.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $1.98 Million - $4.18 Million	-45,000 Reduced 12.12%	326,378 $30.1 Million
Q3 2023 Nov 14, 2023	SELL	$46.9 - $66.0 $11.7 Million - $16.4 Million	-248,622 Reduced 40.1%	371,378 $18.7 Million
Q2 2023 Aug 14, 2023	SELL	$42.2 - $66.37 $2.11 Million - $3.32 Million	-50,000 Reduced 7.46%	620,000 $39.2 Million
Q1 2023 May 15, 2023	SELL	$37.97 - $50.0 $30.7 Million - $40.4 Million	-807,800 Reduced 54.66%	670,000 $30.1 Million
Q4 2022 Feb 14, 2023	SELL	$41.06 - $66.48 $9.12 Million - $14.8 Million	-222,200 Reduced 13.07%	1,477,800 $64.7 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $27.5 Million - $42.7 Million	550,000 Added 47.83%	1,700,000 $112 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $18.1 Million - $28.1 Million	-400,000 Reduced 25.81%	1,150,000 $58.1 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $29.3 Million - $50.2 Million	610,000 Added 64.89%	1,550,000 $90.6 Million
Q2 2019 Aug 13, 2019	BUY	$73.54 - $97.8 $6.72 Million - $8.93 Million	91,352 Added 10.76%	940,000 $0
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $10.2 Million - $18.1 Million	208,648 Added 32.6%	848,648 $67.9 Million
Q4 2018 Feb 13, 2019	SELL	$45.57 - $74.26 $5.01 Million - $8.17 Million	-110,000 Reduced 14.67%	640,000 $34.5 Million
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $6.77 Million - $9.01 Million	115,000 Added 18.11%	750,000 $58.5 Million
Q2 2018 Aug 14, 2018	BUY	$60.96 - $101.18 $17.5 Million - $29 Million	287,000 Added 82.47%	635,000 $40.3 Million
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $3.15 Million - $4.42 Million	50,000 Added 16.78%	348,000 $26.2 Million
Q3 2017 Nov 14, 2017	BUY	$42.37 - $69.67 $12.6 Million - $20.8 Million	298,000	298,000 $20.8 Million

Others Institutions Holding BPMC

# of Institutions

340

Shares Held

62M

Call Options Held

987K

Put Options Held

578K

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.14B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Account

Casdin Capital, LLC Blueprint Medicines Corp Transaction History